PER 0.00% 10.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-31

  1. 3,111 Posts.
    lightbulb Created with Sketch. 612
    Agree Sam however I dont forget or forgive so easily.
    This years AGM will receive an against vote for remuneration, same as i voted last.

    The only thing that will sway my vote the other way is if the Diamond can pull a miracle from his a$$ and get this somewhere near 17c.

    I highly doubt it in the timeframe i have given, but hes had enough time IMO and he's chewing through far too much company money going into his pay packet each month. No sane person can deny this.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.